Skip to main content
logo
Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
1.050
-0.040 (-3.67%)
At close: Dec 5, 2025, 4:00 PM EST
1.020
-0.030 (-2.86%)
After-hours: Dec 5, 2025, 7:31 PM EST

Basel Medical Group Income Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22
Operating Revenue
11.3210.059.710.66
Other Revenue
0.790.390.05-
Revenue
12.1110.449.7510.66
Revenue Growth (YoY)
16.00%7.08%-8.55%-
Cost of Revenue
8.925.895.582.72
Gross Profit
3.184.554.167.94
Selling, General & Admin
0.750.71.055.78
Other Operating Expenses
2.490.740.55-0.31
Operating Expenses
4.421.972.165.48
Operating Income
-1.242.5822.46
Interest Expense
-0.2-0.18-0.24-0.32
Interest & Investment Income
0.08-0.30.25
Other Non Operating Income (Expenses)
--0.07-
EBT Excluding Unusual Items
-1.362.42.132.39
Impairment of Goodwill
-11.15---
Pretax Income
-12.512.42.132.39
Income Tax Expense
-0.420.330.350.41
Earnings From Continuing Operations
-12.092.071.781.98
Minority Interest in Earnings
0---
Net Income
-12.092.071.781.98
Net Income to Common
-12.092.071.781.98
Net Income Growth
-16.23%-9.84%-
Shares Outstanding (Basic)
19161616
Shares Outstanding (Diluted)
19161616
Shares Change (YoY)
15.60%---
EPS (Basic)
-0.640.130.110.12
EPS (Diluted)
-0.640.130.110.12
EPS Growth
-16.23%-9.84%-
Free Cash Flow
-15.392.52.592.7
Free Cash Flow Per Share
-0.820.150.160.17
Gross Margin
26.29%43.59%42.71%74.48%
Operating Margin
-10.23%24.73%20.55%23.09%
Profit Margin
-99.84%19.86%18.30%18.56%
Free Cash Flow Margin
-127.08%23.97%26.61%25.37%
EBITDA
-1.132.612.032.48
EBITDA Margin
-9.35%25.02%20.86%23.30%
D&A For EBITDA
0.110.030.030.02
EBIT
-1.242.5822.46
EBIT Margin
-10.23%24.73%20.55%23.09%
Effective Tax Rate
-13.80%16.34%17.12%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q